Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine Plus Cytarabine With G-CSF in High-Risk MDS
NCT00503880Phase 2Terminated
- Sponsor
- University of Nebraska
- Start
- May 2007
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in myelodysplastic syndrome (MDS), sponsored by University of Nebraska. Started May 2007; status: terminated.
02
Drugs
clofarabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00503880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503880.